FDA OKs First-in-Class HIV Therapy for Patients With Few Options
Fostemsavir (Rukobia) is indicated for heavily treatment-experienced patients living with multidrug-resistant HIV infection. FDA Approvals …read more
Fostemsavir (Rukobia) is indicated for heavily treatment-experienced patients living with multidrug-resistant HIV infection. FDA Approvals …read more